DCM
HITK

Dupont Capital Management’s HI-TECH PHARMACAL INC HITK Stock Holding History

Dupont Capital Management’s Portfolio HITK Stock Details HITK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-98,586
Closed -$3.27M – 678
2013
Q2 		$3.27M Buy
+98,586
New +$3.28M 0.06% 273

Other funds holding HITK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dupont Capital Management's HITK Position: Q3 2013 in Review

Dupont Capital Management sold out of HI-TECH PHARMACAL INC (HITK) in Q3 2013, closing a stake of 98,586 shares — an estimated $3.27M sold.

Dupont Capital Management first reported a position in HITK in Q2 2013 and held it in 1 quarter. The position peaked at $3.27M in Q2 2013. 105 funds tracked by Wall St. Rank hold HITK as of Q3 2013.

  • Dupont Capital Management reported no remaining HI-TECH PHARMACAL INC position as of Q3 2013 after selling out during the quarter.
  • Dupont Capital Management sold 98,586 HI-TECH PHARMACAL INC shares in Q3 2013, an estimated $3.27M.
  • Dupont Capital Management first reported a position in HI-TECH PHARMACAL INC in Q2 2013 and held it in 1 quarter.
  • Dupont Capital Management's HI-TECH PHARMACAL INC position peaked at $3.27M in Q2 2013.
  • 105 funds tracked by Wall St. Rank held HI-TECH PHARMACAL INC as of Q3 2013.

Based on Dupont Capital Management's 13F filing for Q3 2013, filed 13 Nov 2013.